Report on first inflight data of bepicolombo’s mercury orbiter radio-science experiment

BepiColombo’s Mercury Orbiter Radio-science Experiment (MORE) was conceived to enable extremely accurate radio tracking measurements of the Mercury Planetary Orbiter to precisely determine the gravity field and rotational state of Mercury, and to test theories of gravitation (e. g. Einstein’s Theory of General Relativity). The design accuracy of the radio tracking data was 0.004 mm/sec (at 1000 s integration time) for range-rate measurements and 20 cm for range (at a few seconds of integration time). These accuracies are attained due to a combination of simultaneous two-way microwave links at X (7.2-8.4 GHz) and Kaband (32-34 GHz) to calibrate the dispersive plasma noise component. In this letter, we present the first analysis of range and range-rate data collected by ESA’s deep space antenna (DSA) during the initial cruise phase of BepiColombo. The novel 24 Mcps pseudo-noise (PN) modulation of the Ka-band carrier, enabled by MORE’s Ka-band Transponder (KaT), built by Thales Alenia Space Italy, provided two-way range measurements to centimeterlevel accuracy, with an integration time of 4.2 s at 0.29 astronomical units. In tracking passes with favorable weather conditions, range-rate measurements attained an average accuracy of 0.01 mm/s at 60 s integration time. Data from 20 to 24 May 2019 were combined in a multi-pass analysis to test the link stability on a longer timescale. The results confirm the noise level observed with the single-pass analysis and provide a preliminary indication that the MORE PN ranging system at 24 Mcps is compatible with the realization of an absolute measurement, where the need to introduce range biases in the orbital fit is much more limited than in the past. We show that in the initial cruise test the BepiColombo radio link provided range measurements of unprecedented accuracy for a planetary mission, and that, in general, all target accuracies for radio-metric measurements were exceeded

Gravity, Geodesy and Fundamental Physics with BepiColombo’s MORE Investigation

open40siThe Mercury Orbiter Radio Science Experiment (MORE) of the ESA mission BepiColombo will provide an accurate estimation of Mercury’s gravity field and rotational state, improved tests of general relativity, and a novel deep space navigation system. The key experimental setup entails a highly stable, multi-frequency radio link in X and Ka band, enabling two-way range rate measurements of 3 micron/s at nearly all solar elongation angles. In addition, a high chip rate, pseudo-noise ranging system has already been tested at 1-2 cm accuracy. The tracking data will be used together with the measurements of the Italian Spring Accelerometer to provide a pseudo drag free environment for the data analysis. We summarize the existing literature published over the past years and report on the overall configuration of the experiment, its operations in cruise and at Mercury, and the expected scientific results.openIess L.; Asmar S.W.; Cappuccio P.; Cascioli G.; De Marchi F.; di Stefano I.; Genova A.; Ashby N.; Barriot J.P.; Bender P.; Benedetto C.; Border J.S.; Budnik F.; Ciarcia S.; Damour T.; Dehant V.; Di Achille G.; Di Ruscio A.; Fienga A.; Formaro R.; Klioner S.; Konopliv A.; Lemaitre A.; Longo F.; Mercolino M.; Mitri G.; Notaro V.; Olivieri A.; Paik M.; Palli A.; Schettino G.; Serra D.; Simone L.; Tommei G.; Tortora P.; Van Hoolst T.; Vokrouhlicky D.; Watkins M.; Wu X.; Zannoni M.Iess L.; Asmar S.W.; Cappuccio P.; Cascioli G.; De Marchi F.; di Stefano I.; Genova A.; Ashby N.; Barriot J.P.; Bender P.; Benedetto C.; Border J.S.; Budnik F.; Ciarcia S.; Damour T.; Dehant V.; Di Achille G.; Di Ruscio A.; Fienga A.; Formaro R.; Klioner S.; Konopliv A.; Lemaitre A.; Longo F.; Mercolino M.; Mitri G.; Notaro V.; Olivieri A.; Paik M.; Palli A.; Schettino G.; Serra D.; Simone L.; Tommei G.; Tortora P.; Van Hoolst T.; Vokrouhlicky D.; Watkins M.; Wu X.; Zannoni M

Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population

A Moiré Deflectometer for Antimatter

The precise measurement of forces is one way to obtain deep insight into the fundamental interactions present in nature. In the context of neutral antimatter, the gravitational interaction is of high interest, potentially revealing new forces that violate the weak equivalence principle. Here we report on a successful extension of a tool from atom optics - the moirè deflectometer - for a measurement of the acceleration of slow antiprotons. The setup consists of two identical transmission gratings and a spatially resolving emulsion detector for antiproton annihilations. Absolute referencing of the observed antimatter pattern with a photon pattern experiencing no deflection allows the direct inference of forces present. The concept is also straightforwardly applicable to antihydrogen measurements as pursued by the AEgIS collaboration. The combination of these very different techniques from high energy and atomic physics opens a very promising route to the direct detection of the gravitational acceleration of neutral antimatter

AEgIS Experiment: Measuring the Acceleration g of the Earth's Gravitational Field on Antihydrogen Beam

The AEgIS experiment [1] aims at directly measuring the gravitational acceleration g on a beam of cold antihydrogen (H) to a precision of 1%, performing the first test with antimatter of the (WEP) Weak Equivalence Principle. The experimental apparatus is sited at the Antiproton Decelerator (AD) at CERN, Geneva, Switzerland. After production by mixing of antiprotons with Rydberg state positronium atoms (Ps), the atoms will be driven to fly horizontally with a velocity of a few 100 ms−1 for a path length of about 1 meter. The small deflection, few tens of μm, will be measured using two material gratings (of period ∼ 80 μm) coupled to a position-sensitive detector working as a moiré deflectometer similarly to what has been done with matter atoms [2]. The shadow pattern produced by the beam will then be detected by reconstructing the annihilation points with a spatial resolution (∼ 2 μm) of each antiatom at the end of the flight path by the sensitive-position detector. During 2012 the experimental apparatus has been commissioned with antiprotons and positrons. Since the AD will not be running during 2013,during the refurbishment of the CERN accelerators, the experiment is currently working with positrons, electrons and protons, in order to prepare the way for the antihydrogen production in late 2014

Mitochondrial physiology

As the knowledge base and importance of mitochondrial physiology to evolution, health and disease expands, the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive force provides the framework for developing a consistent theoretical foundation of mitochondrial physiology and bioenergetics. We follow the latest SI guidelines and those of the International Union of Pure and Applied Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems and thermodynamics of irreversible processes. The concept-driven constructive terminology incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to reproducibility between laboratories and thus support the development of data repositories of mitochondrial respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature facilitate effective transdisciplinary communication, education, and ultimately further discovery

Mitochondrial physiology

As the knowledge base and importance of mitochondrial physiology to evolution, health and disease expands, the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive force provides the framework for developing a consistent theoretical foundation of mitochondrial physiology and bioenergetics. We follow the latest SI guidelines and those of the International Union of Pure and Applied Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems and thermodynamics of irreversible processes. The concept-driven constructive terminology incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to reproducibility between laboratories and thus support the development of data repositories of mitochondrial respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature facilitate effective transdisciplinary communication, education, and ultimately further discovery

L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

The World Health Organization foresees the elimination of HCV infection by 2030. In light of this and the curre nt, nearly worldwide, restriction in direct-acting agents (DAA) accessibility due to their high price, we aimed to evaluate the cost-effectiveness of two alternative DAA treatment policies: Policy 1 (universal): treat all patients, regardless of the fibrosis stage; Policy 2 (prioritized): treat only priori tized patients and delay treatment of the remaining patients until reaching stage F3. T he model was based on patient’s data from the PITER cohort. We demonstrated that extending HC V treatment of patients in any fibrosis stage improves health outcomes and is cost-effective